NF-kappa B inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis

Toxins convertthe hepatocellular response to tumor necrosis factor- (TNF-)stimulation from proliferation to cell death, suggesting thathepatotoxins somehow sensitize hepatocytes to TNF- toxicity. Becausenuclear factor-B (NF-B) activation confers resistance to TNF-cytotoxicity in nonhepatic cells, the possibility that toxin-inducedsensitization to TNF- killing results from inhibition ofNF-B-dependent gene expression was examined in the RALA rathepatocyte cell line sensitized to TNF- cytotoxicity by actinomycinD (ActD). ActD did not affect TNF--induced hepatocyte NF-Bactivation but decreased NF-B-dependent gene expression. Expressionof an IB superrepressor rendered RALA hepatocytes sensitive toTNF--induced apoptosis in the absence of ActD. Apoptosis was blockedby caspase inhibitors, and TNF- treatment led to activation ofcaspase-2, caspase-3, and caspase-8 only when NF-B activation wasblocked. Although apoptosis was blocked by the NF-B-dependent factornitric oxide (NO), inhibition of endogenous NO production did notsensitize cells to TNF--induced cytotoxicity. Thus NF-Bactivation is the critical intracellular signal that determines whetherTNF- stimulates hepatocyte proliferation or apoptosis. Althoughexogenous NO blocks RALA hepatocyte TNF- cytotoxicity, endogenousproduction of NO is not the mechanism by which NF-B activationinhibits this death pathway.

     

TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes

Obesity is associated with hyperinsulinemia and elevatedconcentrations of tumor necrosis factor- (TNF-) inadipose tissue. TNF- has been implicated as an inducer of thesynthesis of plasminogen activator inhibitor-1 (PAI-1), the primaryphysiological inhibitor of fibrinolysis, mediated by plasminogenactivators in cultured adipocytes. To identify mechanism(s) throughwhich TNF- induces PAI-1, 3T3-L1 preadipocytes were differentiatedinto adipocytes and exposed to TNF- for 24 h. TNF- selectivelyincreased the synthesis of PAI-1 without increasing activity ofplasminogen activators. Both superoxide (generated by xanthine oxidaseplus hypoxanthine) and hydrogen peroxide were potent inducers of PAI-1, and hydroxyl radical scavengers completely abolished the TNF- induction of PAI-1. Exposure of adipocytes to TNF- or insulin aloneover 5 days increased PAI-1 production. These agonists exert synergistic effects. Results obtained suggest that TNF- stimulates PAI-1 production by adipocytes, an effect potentiated by insulin, andthat adipocyte generation of reactive oxygen centered radicals mediatesthe induction of PAI-1 production by TNF-. Because induction ofPAI-1 by TNF- is potentiated synergistically by insulin, both agonists appear likely to contribute to the impairment of fibrinolytic system capacity typical in obese, hyperinsulinemic patients.

     

p38 MAPK mediates renal tubular cell TNF-{alpha} production and TNF-{alpha}-dependent apoptosis during simulated ischemia

Ischemia causes renal tubular cellloss through apoptosis; however, the mechanisms of this processremain unclear. Using the renal tubular epithelial cell lineLLC-PK₁, we developed a model of simulated ischemia(SI) to investigate the role of p38 MAPK (mitogen-activated proteinkinase) in renal cell tumor necrosis factor- (TNF-) mRNAproduction, protein bioactivity, and apoptosis. Resultsdemonstrate that 60 min of SI induced maximal TNF- mRNA productionand bioactivity. Furthermore, 60 min of ischemia induced renaltubular cell apoptosis at all substrate replacement time pointsexamined, with peak apoptotic cell death occurring after either 24 or 48 h. p38 MAPK inhibition abolished TNF- mRNA production andTNF- bioactivity, and both p38 MAPK inhibition and TNF- neutralization (anti-porcine TNF- antibody) preventedapoptosis after 60 min of SI. These results constitute theinitial demonstration that 1) renal tubular cells produceTNF- mRNA and biologically active TNF- and undergoapoptosis in response to SI, and 2) p38 MAPKmediates renal tubular cell TNF- production and TNF--dependent apoptosis after SI.

     

Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-alpha

Uncoupling protein-2 (UCP-2) is amitochondrial protein expressed in adipocytes and has recently beeninvolved in the control of energy dissipation. Because obesity ischaracterized by an imbalance between energy intake and expenditure andby an enhanced adipocyte-derived secretion of tumor necrosis factor-(TNF-), we asked whether TNF- could directly influence UCP-2expression in adipocytes. Experiments performed in differentiated3T3F442A preadipocytes showed that TNF- (10 ng/ml) induced areduction of UCP-2 trancripts, assessed by Northern blot analysis. Asignificant decrease in UCP-2 expression (40%) was observed after 12 and 24 h of TNF- stimulation of the cells. The characterizationof the mechanisms responsible for the TNF- effect on UCP-2expression demonstrates an involvement of the TNF--induced inducible(i) nitric oxide synthase (NOS) expression. Cell treatment with the NOSinhibitor N^G-nitro-L-arginine methylester (L-NAME; 1 mmol/l) significantly diminished theTNF--mediated sustained downregulation of UCP-2 expression, whereascell treatment with a nitric oxide (NO) donor (10³ mol/lS-nitroso-L-glutathione) mimicked the TNF-effect on UCP-2 expression. Moreover, Western blot analysis clearlyshowed that TNF- alone induces the expression of iNOS after12-24 h treatment of differentiated 3T3F442A cells. Theseexperiments demonstrate that TNF- directly downregulates UCP-2expression via NO-dependent pathways that involve the induction of iNOS expression.

     

Effect of TNF-alpha on SMIT mRNA levels and myo-inositol accumulation in cultured endothelial cells

Previously we have shown that hyperosmolarity increasesNa⁺-myo-inositolcotransporter (SMIT) activity and mRNA levels in cultured endothelialcells. Because hyperosmolarity and cytokines, such as tumor necrosisfactor- (TNF-), activate similar signal transduction pathways, weexamined the effect of TNF- on SMIT mRNA levels andmyo-inositol accumulation. In contrastto the effect of hyperosmolarity, TNF- caused a time- andconcentration-dependent decrease in SMIT mRNA levels andmyo-inositol accumulation. The effectof TNF- on myo-inositolaccumulation was found in large-vessel endothelial cells (derived fromthe aorta and pulmonary artery) and cerebral microvessel endothelialcells. In bovine aorta and bovine pulmonary artery endothelial cells,TNF- activated nuclear factor (NF)-B. TNF- also increasedceramide levels, and C₂-ceramidemimicked the effect of TNF- on SMIT mRNA levels andmyo-inositol accumulation in bovineaorta endothelial cells. Pyrrolidinedithiocarbamate, genistein, and7-amino-1-chloro-3-tosylamido-2-hepatanone, compounds that can inhibitNF-B activation, partially prevented the TNF--induced decrease inmyo-inositol accumulation. The effectof TNF- on myo-inositolaccumulation was also partially prevented by the protein kinase Cinhibitor calphostin C but not by staurosporine. These studiesdemonstrate that TNF- causes a decrease in SMIT mRNA levels andmyo-inositol accumulation in culturedendothelial cells, which may be related to the activation of NF-B.

     

Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression

To delineate themechanisms that facilitate leukocyte migration into the cystic fibrosis(CF) lung, expression of chemokines, including interleukin-8 (IL-8),monocyte chemoattractant protein-1 (MCP-1), andRANTES, was compared between CF and non-CF airway epithelia. Thefindings presented herein demonstrate that, under either basalconditions or tumor necrosis factor- (TNF-)- and/or interferon- (IFN-)-stimulated conditions, a consistent pattern ofdifferences in the secretion of IL-8 and MCP-1 between CF and non-CFepithelial cells was not observed. In contrast, CF epithelial cellsexpressed no detectable RANTES protein or mRNA under basal conditionsor when stimulated with TNF- and/or IFN-(P  0.05), unlike their non-CFcounterparts. Correction of the CF transmembrane conductance regulator(CFTR) defect in CF airway epithelial cells restored the induction ofRANTES protein and mRNA by TNF- in combination with IFN-(P  0.05) but had little effect onIL-8 or MCP-1 production compared with mock controls. Transfection studies utilizing RANTES promoter constructs suggested that CFTR activates the RANTES promoter via a nuclear factor-B-mediated pathway. Together, these results suggest that1) RANTES expression is altered inCF epithelia and 2) epithelialexpression of RANTES, but not IL-8 or MCP-1, is dependent on CFTR.     

Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils

Tumor necrosis factor-(TNF-) triggers degranulation and oxygen radical release in adherentneutrophils. The p60TNF receptor (p60TNFR) is responsible forproinflammatory signaling, and protein kinase C (PKC) is a candidatefor the regulation of p60TNFR. Both TNF- and the PKC-activatorphorbol 12-myristate 13-acetate triggered phosphorylation of p60TNFR.Receptor phosphorylation was on both serine and threonine but not ontyrosine residues. The PKC- isotype is a candidate enzyme for serinephosphorylation of p60TNFR. Staurosporine and the PKC- inhibitorrottlerin inhibited TNF--triggered serine but not threoninephosphorylation. Serine phosphorylation was associated withreceptor desensitization, as inhibition of PKC resulted in enhanceddegranulation (elastase release). After neutrophil activation, PKC-was the only PKC isotype that associated with p60TNFR within thecorrect time frame for receptor phosphorylation. In vitro, onlyPKC-, but not the -, I-, II-, or -isotypes, wascompetent to phosphorylate the receptor, indicating that p60TNFR is adirect substrate for PKC-. These findings suggest a selective rolefor PKC- in negative regulation of the p60TNFR and ofTNF--induced signaling.

     

Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages

The APO-1/Fasligand (FasL) and tumor necrosis factor- (TNF-) are twofunctionally related molecules that induce apoptosis ofsusceptible cells. Although the two molecules have been reported toinduce apoptosis via distinct signaling pathways, we have shown that FasL can also upregulate the expression of TNF-, raising thepossibility that TNF- may be involved in FasL-inducedapoptosis. Because TNF- gene expression is under the controlof nuclear factor-B (NF-B), we investigated whether FasL caninduce NF-B activation and whether such activation plays a role inFasL-mediated cell death in macrophages. Gene transfection studiesusing NF-B-dependent reporter plasmid showed that FasL did activateNF-B promoter activity. Gel shift studies also revealed that FasLmobilized the p50/p65 heterodimeric form of NF-B. Inhibition ofNF-B by a specific NF-B inhibitor, caffeic acid phenylethylester, or by dominant expression of the NF-B inhibitory subunitIB caused an increase in FasL-induced apoptosis and areduction in TNF- expression. However, neutralization of TNF- byspecific anti-TNF- antibody had no effect on FasL-inducedapoptosis. These results indicate that FasL-mediated cell deathin macrophages is regulated through NF-B and is independent ofTNF- activation, suggesting the antiapoptotic role of NF-Band a separate death signaling pathway mediated by FasL.

     

Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide

Brief "preconditioning" ischemia inducesischemic tolerance (IT) and protects the animal brain from subsequentotherwise lethal ischemia. Identification of the signalingsteps most proximal to the development of the IT will allow inductionof the resistance to ischemia shortly after the onset ofstroke. Animal studies demonstrate a key role of tumor necrosisfactor- (TNF-) in induction of IT. The sphingolipid ceramide isknown as a second messenger in many of the multiple effects of TNF-.We hypothesized that ceramide could mediate IT. We demonstrate thatpreconditioning of rat cortical neurons with mild hypoxia protects themfrom hypoxia and O₂-glucosedeprivation injury 24 h later (50% protection). TNF- pretreatmentcould be substituted for hypoxic preconditioning (HP). HP wasattenuated by TNF--neutralizing antibody. HP and TNF-pretreatment cause a two- to threefold increase of intracellular ceramide levels, which coincides with the state of tolerance. FumonisinB₁, an inhibitor of ceramidesynthase, attenuated ceramide upregulation and HP. C-2 ceramide addedto the cultures right before the hypoxic insult mimicked the effect ofHP. Ceramide did not induce apoptosis. These results suggest that HP ismediated via ceramide synthesis triggered by TNF-.

     

Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1alpha and tumor necrosis factor-alpha

Work from this and other laboratories has identified a role forprotein tyrosine kinases in interleukin-1 (IL-1)- and tumor necrosis factor- (TNF-)-induced responses in endothelial cells. In this study, we show that activation of human umbilical vein endothelial cells (HUVEC) by IL-1 leads to increased tyrosine phosphorylation of several proteins including one with a molecular massof ~42 kDa. This protein was identified asp42^mapk by Western blot analysis.Tyrosine phosphorylation and catalytic activation ofp42^mapk by IL-1 was transient,reaching maximal levels after 30 min and returning to basal levels by120-300 min. Activation ofp42^mapk in HUVEC was also observedin response to TNF- or to the protein kinase C (PKC)-activatingphorbol ester phorbol 12-myristate 13-acetate (PMA). Pretreatment ofHUVEC with IL-1 or TNF- prevented reactivation ofp42^mapk by either cytokine but didnot affect subsequent activation in response to PMA. Activation ofp42^mapk by PMA was significantlyreduced by the PKC inhibitor Ro-31-8220 and completely inhibited by theprotein tyrosine kinase inhibitor genistein. Genistein, but notRo-31-8220, attenuated IL-1- and TNF--inducedp42^mapk activation. Takentogether, the results of this study demonstrate 1) thatp42^mapk is transiently activatedin HUVEC by IL-1 and TNF-, 2)that this activation is PKC independent, and3) that a genistein-inhibitable tyrosine kinase may be an upstream regulator of cytokine-induced p42^mapk activation in humanendothelium.

     

Monocyte/macrophages evoke epithelial dysfunction: indirect role of tumor necrosis factor-alpha

We examined theability of monocytes (M) activated by bacterial products to alterepithelial physiology. Confluent monolayers of the T84 colonicepithelial cell line were grown on filter supports and then coculturedin the presence of human M with or without the activating agentsbacterial lipopolysaccharide and the bacterial tripeptideformyl-methionyl-leucyl-phenylalanine. After 24 or 48 h, monolayerswere mounted in Ussing chambers where parameters of epithelial functionwere measured. Exposure to activated M resulted in a significantincrease (P < 0.05) in baselineshort-circuit current (250% after 48 h) that was associated withenhanced secretion of Cl.In addition, epithelial permeability was significantly increased asshown by reduced transepithelial resistance and increased flux of⁵¹Cr-EDTA. Activated M producedsubstantial amounts (~3 ng/ml at 48 h) of tumor necrosis factor-(TNF-). TNF- was identified as a key mediator acting via anautocrine mechanism to induce epithelial pathophysiology. Our data showthat M, when activated by common bacterial components, are potenteffector cells capable of initiating significant changes in thetransport and barrier properties of a model epithelium.

     

Time-dependent changes in myosin heavy chain mRNA and protein isoforms in unloaded soleus muscle of rat

Time-dependent changes in myosin heavy chain(MHC) isoform expression were investigated in rat soleus muscleunloaded by hindlimb suspension. Changes at the mRNA level weremeasured by RT-PCR and correlated with changes in the pattern of MHCprotein isoforms. Protein analyses of whole muscle revealed that MHCIdecreased after 7 days, when MHCIIa had increased, reaching a transient maximum by 15 days. Longer periods led to inductions and progressive increases of MHCIId(x) and MHCIIb. mRNA analyses of whole muscle showedthat MHCIId(x) displayed the steepest increase after 4 days andcontinued to rise until 28 days, the longest time period investigated.MHCIIb mRNA followed a similar time course, although at lower levels.MHCI mRNA, present at extremely low levels in control soleus, peakedafter 4 days, stayed elevated until 15 days, and then decayed.Immunohistochemistry of 15-day unloaded muscles revealed that MHCIwas present in muscle spindles but at low amounts also in extrafusalfibers. The slow-to-fast transitions thus seem to proceed in the orderMHCI  MHCIIa  MHCIId(x)  MHCIIb. Ourfindings indicate that MHCI is transiently upregulated in somefibers as an intermediate step during the transition from MHCI to MHCIIa.

     

TNF-alpha potentiates the ion secretion induced by muscarinic receptor activation in HT29cl.19A cells

Chronic gastrointestinaldiseases such as ulcerative colitis and Crohn's disease arecharacterized by severe diarrhea. Mucosal biopsies of these patientsshow enhanced levels of cytokines, secreted by infiltrated inflammatorycells. In this study, we investigated the effect of the cytokine tumornecrosis factor- (TNF-) on ion secretion in human intestinalepithelial cells. The conventional microelectrode technique in the cellline HT29cl.19A was used, which allows for simultaneous measurements oftransepithelial potential difference and intracellular potentialdifference across the apical membrane. Preincubation (2-78 h) with10 ng/ml TNF- did not change basal secretory activity. However, thesecretory response to the muscarinic receptor agonist carbachol wasstrongly increased after exposure to TNF-. Application of theprotein kinase C (PKC) inhibitor GF 109203X (bisindolylmaleimide I)inhibited the response to carbachol as well as the TNF--potentiatedresponse, indicating that PKC mediates the effect of carbachol in thiscell line. Propranolol, a substance that inhibits the phospholipase D(PLD) pathway, strongly reduced the response to muscarinic stimulation and its potentiation by TNF-. The results indicate that activation of PLD is involved in ion secretion induced by muscarinic receptor activation and that TNF- can potentiate this pathway.

     

Resistance to TNF-alpha cytotoxicity can be achieved through different signaling pathways in rat mesangial cells

We reported previously that Ro-318220 blocked expression ofmitogen-activated protein kinase phosphatase-1 (MKP-1) induced by tumornecrosis factor- (TNF-) and subsequently caused apopotosis inmesangial cells (Y.-L. Guo, B. Kang, and J. R. Williamson. J. Biol. Chem. 273: 10362-10366,1998). These data support our hypothesis that a TNF--induciblephosphatase may be responsible for preventing sustained activation ofc-Jun NH₂-terminal protein kinase(JNK) and consequent cell death in these cells (Y.-L. Guo, K. Baysal,B. Kang, L.-J. Yang, and J. R. Williamson. J. Biol. Chem. 273: 4027-4034, 1998). In this study, weinvestigated the involvement of protein kinase C (PKC) in regulation ofMKP-1 expression in mesangial cells together with effects on viability.Although originally characterized as a PKC inhibitor, Ro-318220inhibited TNF--induced MKP-1 expression through a mechanism otherthan blocking the PKC pathway. Furthermore, inhibition of the PKCpathway neither significantly affected TNF--induced MKP-1 expression nor made cells susceptible to toxic effect of TNF-. Thus PKC activation is not essential for cells to achieve the resistance toTNF- cytotoxicity displayed by normal mesangial cells. However, activation of PKC by phorbol 12-myristate 13-acetate (PMA) dramatically increased cellular resistance to the apoptotic effect of TNF-. Coincidentally, PMA stimulated MKP-1 expression and suppressed JNKactivation. Therefore, PMA-induced MKP-1 expression may contribute tothe protective effect of PMA. These results provide a mechanistic explanation for previous documentation that PKC activation can rescuesome cells from apopotosis.     

Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells

Interleukin-1(IL-1) and tumor necrosis factor- (TNF-) are two majorcytokines that rise to relatively high levels during systemicinflammation, and the endothelial cell (EC) response to these cytokinesmay explain some of the dysfunction that occurs. To better understandthe cytokine-induced responses of EC at the gene expression level,human umbilical vein EC were exposed to IL-1 or TNF- for varioustimes and subjected to cDNA microarray analyses to study alterations intheir mRNA expression. Of ~4,000 genes on the microarray, expressionlevels of 33 and 58 genes appeared to be affected by treatment withIL-1 and TNF-, respectively; 25 of these genes responded to bothtreatments. These results suggest that the effects of IL-1 andTNF- on EC are redundant and that it may be necessary to suppressboth cytokines simultaneously to ameliorate the systemic response.

     

Induction of TNF-alpha and MnSOD by endotoxin: role of membrane CD14 and Toll-like receptor-4

Endotoxin (LPS) is a potent inducer oftumor necrosis factor- (TNF-) and manganese superoxide dismutase(MnSOD). Recent evidence suggests that LPS induction of TNF- andMnSOD mRNAs is mediated through distinct intracellular signaltransduction pathways. Membrane CD14 (mCD14) and Toll-like receptor-4(TLR4) mediate LPS induction of TNF- in macrophages. In the current study, we evaluated the role of mCD14 and TLR4 in LPS induction ofMnSOD using peritoneal macrophages from CD14 knockout (CD14-KO) miceand mice with the Tlr4 gene point mutation (C3H/HeJ) ordeletion (C57BL/10ScCr). We studied mCD14-dependent (1 and 10 ng/ml)and mCD14-independent (1,000 ng/ml) concentrations of LPS. Compared with control (BALB/c) macrophages, LPS at 1 and 10 ng/ml failed toinduce TNF- or MnSOD mRNA in CD14-KO macrophages. However, LPS at1,000 ng/ml induced TNF- and MnSOD mRNAs equally in macrophages fromCD14-KO and control mice. LPS (1, 10, or 1,000 ng/ml) failed to induceTNF- or MnSOD mRNA and failed to activate nuclear factor-B inC3H/HeJ or C57BL/10ScCr macrophages. Measurements of TNF- and MnSODenzyme activity paralleled TNF- and MnSOD mRNA levels. These datademonstrate that, like TNF-, induction of MnSOD by LPS is mediatedby mCD14 and TLR4 in murine macrophages.

     

Modulation of human neuronal alpha 1E-type calcium channel by alpha 2delta -subunit

Calcium channels are composed of a pore-forming subunit,₁, and at least two auxiliarysubunits, - and₂-subunits. It is well knownthat -subunits regulate most of the properties of the channel. Thefunction of ₂-subunit isless understood. In this study, the effects of the calcium channel₂-subunit on the neuronal_1E voltage-gated calciumchannel expressed in Xenopus oocyteswas investigated without and with simultaneous coexpression of eitherthe _1b- or the_2a-subunit. Most aspects of_1E function were affected by₂. Thus₂ caused a shift in thecurrent-voltage and conductance-voltage curves toward more positivepotentials and accelerated activation, deactivation, and theinstallation of the inactivation process. In addition, the efficiencywith which charge movement is coupled to pore opening assessed bydetermining ratios of limiting conductance to limiting charge movementwas decreased by ₂ byfactors that ranged from 1.6 (P < 0.01) for _1E-channels to 3.0 (P < 0.005) for_1E1b-channels. These results indicate that₂ facilitates the expressionand the maturation of_1E-channels and converts thesechannels into molecules responding more rapidly to voltage.

     

TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide

We havedeveloped a cellular model in which cultured astrocytes and braincapillary endothelial cells preconditioned with tumor necrosisfactor- (TNF-) fail to upregulate intercellular adhesionmolecule-1 (ICAM-1) protein (80% inhibition) and mRNA (30%inhibition) when challenged with TNF- or exposed to hypoxia. Inasmuch as ceramide is known to mediate some of the effects of TNF-, its levels were measured at various times after the TNF- preconditioning. We present evidence for the first time that, in normalbrain cells, TNF- pretreatment causes a biphasic increase ofceramide levels: an early peak at 15-20 min, when ceramide levelsincreased 1.9-fold in astrocytes and 2.7-fold in rat brain capillaryendothelial cells, and a delayed 2- to 3-fold ceramide increase thatoccurs 18-24 h after addition of TNF-. The following findingsindicate that the delayed ceramide accumulation results in cellunresponsiveness to TNF-: 1)coincident timing of the ceramide peak and the tolerance period,2) mimicking of preconditioning byaddition of exogenous ceramide, and3) attenuation of preconditioning byfumonisin B₁, an inhibitor ofceramide synthesis. In contrast to observations in transformed celllines, the delayed ceramide increase was transient and did not induceapoptosis in brain cells.     

TNF receptor I is required for induction of macrophage heat shock protein 70

Expression of heat shock proteins (HSP) is anadaptive response to cellular stress. Stress induces tumor necrosisfactor (TNF)- production. In turn, TNF- induces HSP70 expression.However, osmotic stress or ultraviolet radiation activates TNF-receptor I (TNFR-I) in the absence of TNF-. We postulated thatTNF- receptors are involved in the induction of HSP70 by cellularstress. Peritoneal M were isolated from wild-type (WT), TNF-knockout (KO), and TNFR (I or II) KO mice. Cells were culturedovernight and then heat stressed at 43 ± 0.5°C for 30 minfollowed by a 4-h recovery at 37°C. Cellular HSP70 expression wasinduced by heat stress or exposure to endotoxin [lipopolysaccharide(LPS)] as determined by immunoblotting. HSP70 expression induced byeither heat or LPS was markedly decreased in TNFR-I KO M, whereasTNFR-II KO M exhibited HSP70 expression comparable to that in WTmice. Expression of HSP70 after heat stress in TNF- KO M was alsosimilar to that in WT mice, suggesting that induction of HSP70 byTNFR-I occurs independently of TNF-. In addition, levels ofsteady-state HSP70 mRNA were similar by RT-PCR in WT and TNFR-I KO Mdespite differences in protein expression. Furthermore, the effect of TNFR-I appears to be cell specific, since HSP70 expression in splenocytes isolated from TNFR-I KO was similar to that in WT splenocytes. These studies demonstrate that TNFR-I is required for thesynthesis of HSP70 in stressed M by a TNF-independent mechanism andsupport an intracellular role for TNFR-I.

     

Differential distribution of ERalpha and ERbeta mRNA in intrauterine tissues of the pregnant rhesus monkey

Twoestrogen receptor (ER) isoforms, ER and ER, have been described.However, no information is available in any species regarding thecomparison of ER and ER levels in pregnant intrauterine tissues.We investigated 1) distribution of ER and ER mRNA in myometrium, amnion, choriodecidua, and placenta; 2) theirabundance in intrauterine tissues at term not in labor (NIL) and inspontaneous term labor (STL); and 3) immunolocalization ofER and ER in pregnant rhesus monkey myometrium. Myometrium,amnion, choriodecidua, and placenta were obtained at cesarean sectionfrom monkeys in STL at 156-166 days gestational age(GA) (n = 4) and from control monkeys NIL at140-152 days GA (n = 4). RT-PCR was conducted to determineER and ER and glyceraldehyde-3-phosphate dehydrogenase mRNAabundance in four intrauterine tissues of the pregnant rhesus monkey.The cloned ER PCR fragment was subjected to sequence analysis. ERand ER were localized in the myometrium by immunohistochemistry. Wedemonstrated that 1) rhesus monkey ER shares >97%identity with human ER in the region sequenced; 2) both ERswere expressed in myometrium, amnion, and choriodecidua but not inplacenta in the current study; 3) ER and ER weredifferentially distributed in myometrium and amnion; 4) ERand ER were immunolocalized in myometrial smooth cells and smoothmuscle and endothelial cells of the myometrial blood vessels. Thebiological significance of these quantitative differences in ERsubtypes merits further study.